Feb 25, 2026
Ibogaine for PTSD in Veterans: Real Results from MindScape Retreat's Treatment Protocol
Marcus served three tours in Afghanistan. He came home with a Purple Heart, a medical discharge, and PTSD so severe he c...
Read Article →Understanding the Conditions
Post-Traumatic Stress Disorder (PTSD) and Complex PTSD (CPTSD) are severe mental health conditions triggered by experiencing or witnessing traumatic events. While PTSD arises from a single traumatic incident, CPTSD results from prolonged exposure to trauma. often in contexts where the individual felt trapped, such as in cases of chronic abuse, combat, or captivity. These conditions produce debilitating symptoms including flashbacks, severe anxiety, depression, emotional dysregulation, and a profound sense of detachment from reality.
Traumatic Brain Injury (TBI) adds another dimension: direct structural and neurochemical damage to the brain tissue itself. Inflammation, disrupted neurotransmitter signaling, and impaired neuroplasticity compound the psychological impact of trauma. Traditional treatments such as SSRIs and talk therapy often provide only partial relief, leaving the underlying neurological damage unaddressed and the trauma unresolved at its root.
Conditions We Treat
Whether from combat, assault, accident, or medical trauma, PTSD arising from a single event responds powerfully to ibogaine's ability to facilitate the processing and integration of traumatic memory. transforming it from an active wound into resolved history.
CPTSD from prolonged abuse, neglect, or captivity involves deep identity-level disruptions that single-incident treatments rarely address. Ibogaine's capacity for extended introspective processing gives CPTSD patients access to psychological territory that years of conventional therapy often cannot reach.
Ibogaine's upregulation of GDNF and activation of the sigma-2 receptor promotes neuroregeneration and reduces neuroinflammation. two of the central physiological challenges in TBI recovery. Many TBI patients report meaningful cognitive and emotional improvements following treatment.
Veterans and first responders carry a particular burden: moral injury, operational stress, and traumatic memory layered upon each other across years of service. Ibogaine addresses all of these simultaneously, offering a depth of processing that medication management alone cannot provide.
The Mechanism
Ibogaine's efficacy in treating PTSD and related conditions is rooted in its interaction with the brain's neurochemical pathways. The upregulation of GDNF supports the survival of dopaminergic neurons and promotes neuroplasticity. the brain's ability to reorganize itself by forming new neural connections. By enhancing GDNF levels, ibogaine supports the repair of neural circuits damaged by trauma, facilitating restoration of cognitive function and emotional balance.
Noribogaine. ibogaine's active metabolite. remains in the body for several months post-treatment, binding to the serotonin transporter, sigma-2 receptor, and kappa-opioid receptor. It inhibits serotonin reuptake to improve mood, activates the sigma-2 receptor for neuroprotective and anti-depressive effects, and modulates the kappa-opioid receptor to reduce stress and anxiety without addictive potential. Unlike SSRIs that temporarily increase serotonin, ibogaine promotes a more balanced and sustained enhancement of serotonin signaling. We integrate NAD+ infusions and 5-MeO-DMT alongside ibogaine to further amplify neuroplasticity and deep healing.
MindScape's 14-day trauma protocol incorporates twice-daily ibogaine TA booster doses across multiple consecutive days before the HCl flood session. This extended neurotrophic priming phase initiates BDNF and GDNF upregulation days before the flood dose amplifies both pathways, opening a substantially wider neuroplastic window for trauma processing and neural repair. For TBI patients specifically, early GDNF elevation begins reducing neuroinflammation and supporting oligodendrocyte function before the primary session. The graduated dosing also stabilizes autonomic nervous system function — particularly heart rate variability — which is critical when patients carry trauma-conditioned hyperarousal that would otherwise complicate the emotionally intense flood experience.
Clinical Protocol
Our care team listens first. We learn your trauma history, current medications, prior treatments, and what relief has looked like. and what it has not. This conversation is confidential and carries no obligation.
Full medical intake including EKG cardiac evaluation, complete bloodwork, and liver panel. Patients on SSRIs or other psychiatric medications are guided through a medically supervised taper prior to treatment to ensure safety.
Our medical director and psychologists design your protocol based on your specific conditions. PTSD, CPTSD, TBI, or combinations. calibrating ibogaine dosing, supplemental NAD+, and the inclusion of 5-MeO-DMT as clinically appropriate.
The ibogaine session unfolds over 12 to 24 hours under continuous physician supervision at our Cozumel retreat. Many guests describe encountering and processing core traumatic memories during the experience in ways that feel complete rather than re-traumatizing.
Trauma integration requires time and structure. Our team provides post-treatment support, 90-day integration framework, scheduled coaching, and access to our patient community. ensuring the gains from treatment are consolidated and sustained.
Common Questions
Program Investment
Psilocybin Program
$4,000
5-day, 4-night psilocybin-assisted therapy retreat. All-inclusive with island excursions.
Ibogaine Protocol
$7,500
7 day all-inclusive ibogaine program. Full trauma processing and neurological support.
All pricing includes accommodations, meals, medical supervision, pre-treatment preparation, NAD+ infusions, and 90-day integration support. No hidden fees.
Our medical team will review your history honestly and tell you whether ibogaine treatment is appropriate for your specific situation. The conversation is confidential and carries no obligation.
Request a Confidential ConsultationLatest Research & News
Feb 25, 2026
Marcus served three tours in Afghanistan. He came home with a Purple Heart, a medical discharge, and PTSD so severe he c...
Read Article →Feb 18, 2026
Traumatic brain injury (TBI) affects millions of people worldwide, with veterans, athletes, and accident survivors often...
Read Article →Feb 18, 2026
Post-traumatic stress disorder (PTSD) affects millions of people worldwide, with veterans, first responders, and trauma ...
Read Article →Feb 17, 2026
After decades of limited treatment options, veterans with post-traumatic stress disorder finally have reason for hope. A...
Read Article →